Insmed (INSM) Operating Income Growth (1y) (2011 - 2026)
Insmed (INSM) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 1,386.07% |
| 10 | Insmed | 22.85 Bn | 21.63 Bn | 258.54 Mn | 38.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.21% |
| Dec 31, 2025 | -38.77% |
| Sep 30, 2025 | -71.49% |
| Jun 30, 2025 | -8.30% |
| Mar 31, 2025 | -70.54% |
| Dec 31, 2024 | -29.25% |
| Sep 30, 2024 | -44.53% |
| Jun 30, 2024 | -22.66% |
| Mar 31, 2024 | 1.79% |
| Dec 31, 2023 | -17.69% |
| Sep 30, 2023 | -15.64% |
| Jun 30, 2023 | -166.69% |
| Mar 31, 2023 | -64.93% |
| Dec 31, 2022 | -52.88% |
| Sep 30, 2022 | -23.24% |
| Jun 30, 2022 | 0.28% |
| Mar 31, 2022 | -7.16% |
| Dec 31, 2021 | -4.80% |
| Sep 30, 2021 | -84.30% |
| Jun 30, 2021 | -63.67% |